Abstract Details
|
Shirin Vartak
(Midwestern University AZCOM)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Thomas J. Guttuso, MD | Dr. Guttuso has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Guttuso has received stock or an ownership interest from e3 Pharmaceuticals. |
| Jesper Hagemeier | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Ellen Carl, MS (The Jacobs Neurological Institute) | No disclosure on file |
| David G. Lichter, FRACP, MBChB, FÂ鶹´«Ã½Ó³» (Dept of Neurology, University At Buffalo) | No disclosure on file |
| Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³» (Buffalo Neuroimaging Analysis Center) | The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. |